Why Technology is Key to Unlocking Clinical Trial Access in Underserved Communities
Despite a step change in awareness about the need for diverse participants in clinical trials, ongoing clinical trials in western health systems fail to reflect…
Clinical Trials
The Problem with Clinical Trials (and how virtual insight-gathering can help)
These days, clinical trials are in the news pretty much daily. Whether successful or not, they can impact not only the perception of a pharmaceutical…
Survey Reveals Overwhelmingly Positive Early Experiences of EMA’s New Clinical Trials Information System
European and US pharma companies have welcomed the EMA’s new clinical trials information system (CTIS), according to an Arriello survey. Arriello’s Kieran O’Donnell and Nicola…
Virtual Tools for Promoting Diversity in Pharma and Clinical Trials
It is no secret that Pharma (still) has a major diversity problem. Not only on their own senior leadership teams but also in their clinical…
Modernisation of Clinical Trials Amidst the Pandemic
Globally, researchers have long since been working on various aspects of medicine and clinical trials are a core part of developing medicinal and health development…
Study to Understand Fatal Genetic Diseases in Children becomes First to Incorporate a Digital Participant Education Programme
A pioneering clinical trial has been launched to help researchers understand how two rare and fatal genetic diseases develop in children and provide insight into…
How Virtual Engagement can Build Trust between CROs and Sponsors
Trust between clinical research organisations (CROs) and sponsors – a person or organisation that establishes and supports healthcare plans – is essential for running successful clinical…
The Role of Data Analytics in Improving Clinical Trials and Drug Discovery
The last decade has brought about many developments to genomics, stem cell research, cancer therapies and immunotherapy – to name just a few areas. Hand…
Creating Rare Connections
Leveraging Technology to Bridge the Gap between Patients and Pharma Patient populations for individual rare diseases are usually small and spread out across many geographies…
Leading Clinical Technology Providers Join Forces to Tackle Key Clinical Trial Pain Point
uMotif and Xperiome, a global healthtech company specialising in rare disease are to collaborate through a partnership that will bring value to both life science…